NICOTINE TRANSDERMAL SYSTEM

NICOTINE TRANSDERMAL SYSTEM was reported 4672 times

NICOTINE TRANSDERMAL SYSTEM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NICOTINE ALLERGY 1 0.1667
1 INJURY TO BRACHIAL PLEXUS DUE TO BIRTH TRAUMA 2 0.1429
2 EXPOSURE TO TOBACCO 1 0.1111
3 MEAN PLATELET VOLUME 1 0.0909
4 PLETHYSMOGRAPHY 2 0.0769
5 CANNABIS INTERACTION 1 0.0769
6 APPLICATION SITE HYPERTROPHY 1 0.0714
7 APPLICATION SITE PURPURA 1 0.0625
8 POSTMASTECTOMY LYMPHOEDEMA SYNDROME 1 0.0435
9 CAPUT SUCCEDANEUM 1 0.0345
10 PRODUCT SELECTION ISSUE 1 0.0238
11 END-TIDAL CO2 DECREASED 1 0.0213
12 INFERIOR VENA CAVA STENOSIS 1 0.0204
13 VAGINAL FLATULENCE 6 0.0198
14 SHOULDER DYSTOCIA 2 0.0132
15 LUNG DIFFUSION DISORDER 2 0.0127
16 BACTERIAL TRACHEITIS 1 0.0123
17 IMPLANT SITE DEHISCENCE 1 0.0116
18 ALCOHOL TEST FALSE POSITIVE 1 0.0106
19 DUODENAL NEOPLASM 1 0.0102
20 DEAFNESS CONGENITAL 2 0.0100
21 MYCOBACTERIUM TEST POSITIVE 2 0.0097
22 INVESTIGATION NONCOMPLIANCE 1 0.0092
23 POCKET EROSION 1 0.0090
24 FASCIOTOMY 1 0.0089
25 APPLICATION SITE HYPOAESTHESIA 2 0.0085
26 MEDIASTINAL MASS 3 0.0078
27 BENIGN ETHNIC NEUTROPENIA 1 0.0078
28 APNOEA NEONATAL 2 0.0077
29 SACROILIAC JOINT DYSFUNCTION 1 0.0075
30 MYOCARDIAL STUNNING 1 0.0075
31 CONGENITAL NAEVUS 1 0.0070
32 LUDWIG ANGINA 1 0.0069
33 PRODUCT ADHESION ISSUE 242 0.0068
34 CELLULITIS STREPTOCOCCAL 1 0.0063
35 MEDICAL DEVICE SITE REACTION 1 0.0063
36 APPLICATION SITE WOUND 1 0.0061
37 APPLICATION SITE PERSPIRATION 1 0.0058
38 LYMPH NODE PALPABLE 1 0.0058
39 IDIOPATHIC INTERSTITIAL PNEUMONIA 2 0.0056
40 DIFFICULTY REMOVING DRUG IMPLANT 1 0.0056
41 GENITOURINARY SYMPTOM 1 0.0055
42 RESPIRATORY GAS EXCHANGE DISORDER 2 0.0054
43 ADENOIDECTOMY 2 0.0052
44 NAIL HYPERTROPHY 1 0.0049
45 CONGENITAL MUSCULOSKELETAL ANOMALY 2 0.0045
46 PRODUCT INTOLERANCE 1 0.0045
47 PULMONARY EOSINOPHILIA 2 0.0044
48 NICOTINE DEPENDENCE 33 0.0042
49 INJECTION SITE GRANULOMA 1 0.0042
50 CANCER IN REMISSION 1 0.0041
51 CONVULSION NEONATAL 2 0.0038
52 APPLICATION SITE PRURITUS 82 0.0036
53 OESOPHAGITIS HAEMORRHAGIC 1 0.0036
54 IMMATURE GRANULOCYTE COUNT INCREASED 1 0.0035
55 FEMALE GENITAL TRACT FISTULA 6 0.0035
56 CARBON DIOXIDE ABNORMAL 1 0.0032
57 LUNG LOBECTOMY 1 0.0030
58 PACKAGING DESIGN ISSUE 1 0.0030
59 APPLICATION SITE SWELLING 15 0.0030
60 APPLICATION SITE RASH 41 0.0030
61 NEURODEVELOPMENTAL DISORDER 2 0.0030
62 NON-ALCOHOLIC STEATOHEPATITIS 3 0.0029
63 FOETAL HYPOKINESIA 2 0.0029
64 GASTROINTESTINAL MICROORGANISM OVERGROWTH 1 0.0028
65 FOETAL HEART RATE DECELERATION ABNORMALITY 2 0.0028
66 BRONCHIAL WALL THICKENING 2 0.0028
67 ECLAMPSIA 1 0.0027
68 TOBACCO USER 4 0.0027
69 GENERALISED BULLOUS FIXED DRUG ERUPTION 1 0.0027
70 DIAPHRAGMATIC DISORDER 2 0.0026
71 MYASTHENIC SYNDROME 2 0.0026
72 PARVOVIRUS INFECTION 1 0.0025
73 APPLICATION SITE LACERATION 1 0.0024
74 SYNDACTYLY 2 0.0024
75 CONGENITAL CYSTIC KIDNEY DISEASE 2 0.0024
76 ELEVATED MOOD 1 0.0023
77 CLEFT LIP 2 0.0023
78 RADICULOPATHY 6 0.0023
79 LARGE FOR DATES BABY 2 0.0023
80 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 1 0.0022
81 ENLARGED UVULA 1 0.0022
82 CORONARY ANGIOPLASTY 1 0.0022
83 INCISION SITE ERYTHEMA 1 0.0022
84 PROCTITIS 6 0.0021
85 PRIMARY BILIARY CHOLANGITIS 1 0.0021
86 PYELOCALIECTASIS 2 0.0021
87 APPLICATION SITE BRUISE 2 0.0021
88 DERMATITIS INFECTED 1 0.0020
89 GASTRIC PH DECREASED 2 0.0020
90 APPLICATION SITE PAIN 43 0.0020
91 BRAIN MIDLINE SHIFT 1 0.0019
92 GROIN INFECTION 1 0.0018
93 APPLICATION SITE URTICARIA 4 0.0018
94 MEDICAL DEVICE SITE PAIN 1 0.0018
95 PULMONARY GRANULOMA 2 0.0018
96 CARDIORENAL SYNDROME 1 0.0017
97 ENDOSCOPY 1 0.0017
98 GRUNTING 1 0.0017
99 APPLICATION SITE HYPERSENSITIVITY 2 0.0016
100 APPLICATION SITE ERYTHEMA 43 0.0016
101 SITTING DISABILITY 1 0.0016
102 STERNAL FRACTURE 2 0.0016
103 APPLICATION SITE SCAR 2 0.0016
104 CHRONIC SINUSITIS 6 0.0016
105 JAUNDICE NEONATAL 3 0.0016
106 NECROTISING COLITIS 2 0.0016
107 BRONCHIAL SECRETION RETENTION 2 0.0016
108 PRESSURE OF SPEECH 1 0.0015
109 APPLICATION SITE PARAESTHESIA 2 0.0015
110 APPLICATION SITE BURN 7 0.0014
111 PROPOFOL INFUSION SYNDROME 1 0.0014
112 CERVICAL RADICULOPATHY 1 0.0014
113 MULTIPLE CONGENITAL ABNORMALITIES 2 0.0014
114 DENTAL RESTORATION FAILURE 1 0.0014
115 NASAL INJURY 1 0.0014
116 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
117 CLOSTRIDIUM TEST POSITIVE 3 0.0014
118 AMINO ACID LEVEL INCREASED 1 0.0013
119 TEMPERATURE REGULATION DISORDER 3 0.0013
120 DIZZINESS EXERTIONAL 1 0.0013
121 COMPLICATION OF PREGNANCY 1 0.0013
122 PELVIC MASS 1 0.0012
123 POST-TRAUMATIC NECK SYNDROME 1 0.0012
124 APPLICATION SITE VESICLES 8 0.0012
125 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
126 DYSBIOSIS 1 0.0012
127 EXPOSURE DURING BREAST FEEDING 4 0.0012
128 APPLICATION SITE IRRITATION 15 0.0012
129 TONSILLECTOMY 2 0.0012
130 ELECTRIC SHOCK 1 0.0012
131 LUNG HYPERINFLATION 1 0.0012
132 MYCOBACTERIAL INFECTION 2 0.0012
133 AXONAL NEUROPATHY 1 0.0011
134 DRUG DETOXIFICATION 1 0.0011
135 APPLICATION SITE DISCOMFORT 2 0.0011
136 NASAL OEDEMA 2 0.0011
137 INCISION SITE INFECTION 1 0.0011
138 RED BLOOD CELL COUNT INCREASED 3 0.0011
139 BIOPSY 1 0.0011
140 PENILE SIZE REDUCED 1 0.0011
141 MECHANICAL VENTILATION 2 0.0011
142 PRODUCT AFTER TASTE 1 0.0010
143 HYPERVIGILANCE 1 0.0010
144 CLEFT PALATE 2 0.0010
145 APPLICATION SITE REACTION 7 0.0010
146 POLYHYDRAMNIOS 1 0.0010
147 METASTASES TO SKIN 1 0.0010
148 NIGHTMARE 33 0.0010
149 NASAL INFLAMMATION 1 0.0009
150 BONE DEMINERALISATION 1 0.0009
151 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
152 IRON OVERLOAD 1 0.0009
153 APPLICATION SITE SCAB 2 0.0009
154 PNEUMONIA STREPTOCOCCAL 1 0.0009
155 NEAR DEATH EXPERIENCE 3 0.0009
156 LUMBAR RADICULOPATHY 1 0.0009
157 CHRONIC SPONTANEOUS URTICARIA 1 0.0009
158 PRE-ECLAMPSIA 4 0.0008
159 BRONCHIAL HYPERREACTIVITY 1 0.0008
160 GRANULOMATOSIS WITH POLYANGIITIS 1 0.0008
161 BLOOD IMMUNOGLOBULIN E INCREASED 2 0.0008
162 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA 1 0.0008
163 INTERVERTEBRAL DISC OPERATION 1 0.0008
164 INTRAVENTRICULAR HAEMORRHAGE 2 0.0008
165 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 1 0.0008
166 HYPERAESTHESIA TEETH 1 0.0008
167 ECONOMIC PROBLEM 12 0.0008
168 VAGINAL DISCHARGE 8 0.0008
169 MALLORY-WEISS SYNDROME 1 0.0008
170 APPLICATION SITE WARMTH 1 0.0008
171 ADNEXA UTERI PAIN 1 0.0008
172 APPLICATION SITE EROSION 1 0.0008
173 HYPOVITAMINOSIS 1 0.0008
174 POSTPARTUM HAEMORRHAGE 1 0.0007
175 ABSCESS ORAL 1 0.0007
176 CENTRAL NERVOUS SYSTEM LYMPHOMA 1 0.0007
177 DEATH NEONATAL 1 0.0007
178 HAEMORRHAGE IN PREGNANCY 1 0.0007
179 PULMONARY SEPSIS 1 0.0007
180 ANHEDONIA 18 0.0007
181 AXILLARY PAIN 1 0.0007
182 CHOLANGIOCARCINOMA 1 0.0007
183 MENTAL FATIGUE 1 0.0007
184 METABOLIC ENCEPHALOPATHY 2 0.0007
185 SECONDARY ADRENOCORTICAL INSUFFICIENCY 1 0.0007
186 MOUTH INJURY 1 0.0007
187 PARAINFLUENZAE VIRUS INFECTION 1 0.0007
188 TROPONIN INCREASED 5 0.0007
189 PREMATURE SEPARATION OF PLACENTA 1 0.0006
190 MEAN CELL VOLUME DECREASED 1 0.0006
191 TALIPES 2 0.0006
192 UMBILICAL HERNIA 3 0.0006
193 BACTERIAL VAGINOSIS 1 0.0006
194 FUNGAEMIA 1 0.0006
195 EXPIRED PRODUCT ADMINISTERED 21 0.0006
196 PHARYNGEAL PARAESTHESIA 1 0.0006
197 INCORRECT DOSE ADMINISTERED BY PRODUCT 1 0.0006
198 PARAESTHESIA ORAL 9 0.0006
199 LYMPHOCYTE COUNT INCREASED 2 0.0006
200 INJECTION SITE ATROPHY 1 0.0006
201 GASTRIC DILATATION 1 0.0006
202 MACULAR DEGENERATION 7 0.0006
203 PRODUCT COLOUR ISSUE 3 0.0006
204 CERVICAL SPINAL STENOSIS 1 0.0006
205 FANCONI SYNDROME ACQUIRED 1 0.0006
206 BRONCHIOLITIS 2 0.0006
207 HEART DISEASE CONGENITAL 2 0.0006
208 MITRAL VALVE DISEASE 1 0.0006
209 HAND FRACTURE 4 0.0006
210 ILEAL STENOSIS 1 0.0006
211 SCHIZOAFFECTIVE DISORDER 1 0.0006
212 OPHTHALMIC HERPES ZOSTER 1 0.0006
213 INTENTIONAL PRODUCT MISUSE 48 0.0005
214 ABNORMAL DREAMS 15 0.0005
215 AURA 1 0.0005
216 BONE DENSITY ABNORMAL 2 0.0005
217 PRODUCT LEAKAGE 3 0.0005
218 IMPATIENCE 1 0.0005
219 ORAL CANDIDIASIS 7 0.0005
220 INFECTED SKIN ULCER 1 0.0005
221 NEUTROPHILIA 3 0.0005
222 OSTEOPOROTIC FRACTURE 1 0.0005
223 CLAVICLE FRACTURE 2 0.0005
224 THERAPEUTIC PRODUCT INEFFECTIVE 2 0.0005
225 PRODUCT LABEL CONFUSION 3 0.0005
226 NASAL SEPTUM DEVIATION 1 0.0005
227 JOINT CREPITATION 1 0.0005
228 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
229 PRODUCT SUBSTITUTION ISSUE 28 0.0005
230 QUADRIPLEGIA 1 0.0005
231 SKIN IRRITATION 22 0.0005
232 EYE CONTUSION 1 0.0005
233 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
234 BONE LOSS 7 0.0005
235 HYPERPHOSPHATAEMIA 1 0.0005
236 ABSCESS INTESTINAL 1 0.0005
237 FACIAL PALSY 1 0.0005
238 PERIODONTITIS 1 0.0005
239 OSTEOPENIA 7 0.0005
240 REACTION TO DRUG EXCIPIENTS 1 0.0005
241 ELECTROCARDIOGRAM T WAVE INVERSION 1 0.0005
242 OBSTRUCTIVE AIRWAYS DISORDER 5 0.0004
243 BACTERIAL TEST POSITIVE 1 0.0004
244 FEAR OF DEATH 1 0.0004
245 NEPHROGENIC ANAEMIA 2 0.0004
246 IMPLANT SITE INFECTION 1 0.0004
247 ORAL SURGERY 1 0.0004
248 TIBIA FRACTURE 2 0.0004
249 PULSE ABSENT 2 0.0004
250 OXYGEN CONSUMPTION INCREASED 1 0.0004
251 PULSE ABNORMAL 1 0.0004
252 PREMATURE RUPTURE OF MEMBRANES 1 0.0004
253 ATELECTASIS 4 0.0004
254 LYMPHADENITIS 1 0.0004
255 NASAL POLYPS 2 0.0004
256 HYPERVOLAEMIA 2 0.0004
257 ORTHOSTATIC HYPOTENSION 7 0.0004
258 NERVOUSNESS 21 0.0004
259 CATHETER SITE HAEMORRHAGE 1 0.0004
260 HYPERPARATHYROIDISM SECONDARY 1 0.0004
261 EMPHYSEMA 4 0.0004
262 METASTASES TO PERITONEUM 1 0.0004
263 HYPOTHERMIA 4 0.0004
264 PRODUCT COMPLAINT 10 0.0004
265 APPENDICITIS PERFORATED 1 0.0004
266 PHYSICAL DECONDITIONING 1 0.0004
267 END STAGE RENAL DISEASE 7 0.0004
268 COMPARTMENT SYNDROME 1 0.0004
269 FULL BLOOD COUNT ABNORMAL 4 0.0004
270 ALCOHOL ABUSE 1 0.0004
271 FRUSTRATION TOLERANCE DECREASED 3 0.0004
272 BEHAVIOUR DISORDER 2 0.0004
273 CLONUS 1 0.0004
274 RHINALGIA 1 0.0004
275 DENTAL CARIES 4 0.0004
276 EOSINOPHIL COUNT INCREASED 3 0.0004
277 SKIN HYPERTROPHY 1 0.0004
278 NECK MASS 1 0.0004
279 PANCREATIC CARCINOMA METASTATIC 1 0.0004
280 DUODENAL ULCER HAEMORRHAGE 1 0.0003
281 TREATMENT NONCOMPLIANCE 19 0.0003
282 FIBULA FRACTURE 1 0.0003
283 MOUTH SWELLING 2 0.0003
284 HYPERVENTILATION 2 0.0003
285 PULMONARY PAIN 1 0.0003
286 NECK INJURY 1 0.0003
287 ENERGY INCREASED 2 0.0003
288 CREPITATIONS 1 0.0003
289 LUNG ADENOCARCINOMA 1 0.0003
290 REBOUND ACID HYPERSECRETION 1 0.0003
291 FOETAL GROWTH RESTRICTION 2 0.0003
292 SELF INJURIOUS BEHAVIOUR 1 0.0003
293 BRAIN NEOPLASM 3 0.0003
294 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
295 BLOOD BLISTER 1 0.0003
296 BREAST CANCER RECURRENT 1 0.0003
297 DRUG EFFECT INCREASED 1 0.0003
298 FEELING JITTERY 6 0.0003
299 LOOSE TOOTH 1 0.0003
300 CARDIAC FLUTTER 2 0.0003
301 HEPATITIS ACUTE 2 0.0003
302 POSTURE ABNORMAL 1 0.0003
303 BACTERIAL SEPSIS 1 0.0003
304 PEPTIC ULCER 1 0.0003
305 OLIGOHYDRAMNIOS 1 0.0003
306 POTENTIATING DRUG INTERACTION 1 0.0003
307 PRODUCT LABEL ISSUE 2 0.0003
308 TOOTH ABSCESS 3 0.0003
309 APPLICATION SITE DRYNESS 1 0.0003
310 TACHYPNOEA 4 0.0003
311 CIRCULATORY COLLAPSE 5 0.0003
312 EUPHORIC MOOD 3 0.0003
313 EXTRASYSTOLES 2 0.0003
314 HANGOVER 1 0.0003
315 DEPRESSIVE SYMPTOM 1 0.0003
316 DUODENAL ULCER 2 0.0003
317 THERMAL BURN 2 0.0003
318 SINUS TACHYCARDIA 4 0.0003
319 GLOSSITIS 1 0.0003
320 PRODUCT CONTAMINATION 1 0.0003
321 PYODERMA GANGRENOSUM 1 0.0003
322 RENAL TRANSPLANT 1 0.0003
323 TOOTHACHE 5 0.0003
324 BLOOD PHOSPHORUS DECREASED 1 0.0003
325 ALCOHOL USE 1 0.0003
326 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
327 PULMONARY MASS 4 0.0003
328 MALNUTRITION 3 0.0003
329 MIDDLE INSOMNIA 5 0.0003
330 GENERAL SYMPTOM 2 0.0003
331 FOOT FRACTURE 5 0.0003
332 FACE INJURY 1 0.0003
333 DERMATITIS CONTACT 3 0.0003
334 WITHDRAWAL SYNDROME 11 0.0003
335 ACIDOSIS 2 0.0003
336 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 53 0.0003
337 OESOPHAGEAL ULCER 1 0.0003
338 APNOEA 2 0.0003
339 CERVIX CARCINOMA 1 0.0003
340 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
341 SKIN ODOUR ABNORMAL 1 0.0003
342 PROCEDURAL PAIN 7 0.0003
343 PREMATURE DELIVERY 4 0.0003
344 CEREBRAL ATROPHY 1 0.0003
345 INTRACRANIAL ANEURYSM 1 0.0002
346 DECUBITUS ULCER 2 0.0002
347 HICCUPS 2 0.0002
348 ANAPHYLACTOID REACTION 1 0.0002
349 APPLICATION SITE EXFOLIATION 1 0.0002
350 EMBOLISM 2 0.0002
351 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
352 ACCIDENTAL EXPOSURE 1 0.0002
353 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
354 ERECTION INCREASED 1 0.0002
355 POOR PERIPHERAL CIRCULATION 1 0.0002
356 ABSCESS LIMB 1 0.0002
357 HEPATIC PAIN 1 0.0002
358 PURULENT DISCHARGE 1 0.0002
359 UNRESPONSIVE TO STIMULI 6 0.0002
360 SPINAL OSTEOARTHRITIS 2 0.0002
361 COLD SWEAT 4 0.0002
362 LIMB DISCOMFORT 7 0.0002
363 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 16 0.0002
364 JOINT RANGE OF MOTION DECREASED 3 0.0002
365 BONE DENSITY DECREASED 7 0.0002
366 FREQUENT BOWEL MOVEMENTS 6 0.0002
367 PALPITATIONS 26 0.0002
368 PRODUCT TASTE ABNORMAL 3 0.0002
369 PATHOGEN RESISTANCE 2 0.0002
370 DISEASE COMPLICATION 1 0.0002
371 LUMBAR VERTEBRAL FRACTURE 1 0.0002
372 NIGHT SWEATS 7 0.0002
373 MUSCLE TWITCHING 5 0.0002
374 LOCALISED OEDEMA 1 0.0002
375 ORAL DISCOMFORT 3 0.0002
376 ROSACEA 1 0.0002
377 PERFORMANCE STATUS DECREASED 1 0.0002
378 APPENDICITIS 2 0.0002
379 SKIN TIGHTNESS 1 0.0002
380 FRACTURE 4 0.0002
381 COLITIS 8 0.0002
382 SPUTUM DISCOLOURED 2 0.0002
383 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
384 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
385 PRODUCT PACKAGING ISSUE 2 0.0002
386 GESTATIONAL DIABETES 1 0.0002
387 INCREASED APPETITE 4 0.0002
388 HYPOVOLAEMIC SHOCK 1 0.0002
389 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 10 0.0002
390 FAECAL INCONTINENCE 1 0.0002
391 FINGER DEFORMITY 1 0.0002
392 LIVER FUNCTION TEST ABNORMAL 6 0.0002
393 DRUG WITHDRAWAL SYNDROME NEONATAL 3 0.0002
394 MUCOUS STOOLS 1 0.0002
395 HYPOXIA 7 0.0002
396 SLEEP DISORDER 14 0.0002
397 DRUG INEFFECTIVE 260 0.0002
398 PATHOLOGICAL FRACTURE 1 0.0002
399 DYSLIPIDAEMIA 1 0.0002
400 SKIN DISCOLOURATION 9 0.0002
401 INITIAL INSOMNIA 2 0.0002
402 OSTEOPOROSIS 8 0.0002
403 CACHEXIA 1 0.0002
404 ANKLE FRACTURE 3 0.0002
405 TOOTH LOSS 4 0.0002
406 FAILURE TO THRIVE 1 0.0002
407 MALABSORPTION 1 0.0002
408 PRODUCT ODOUR ABNORMAL 2 0.0002
409 CYANOSIS 3 0.0002
410 RENAL PAIN 2 0.0002
411 MOOD SWINGS 6 0.0002
412 BREAST PAIN 2 0.0002
413 COMPRESSION FRACTURE 1 0.0002
414 PRODUCT SIZE ISSUE 1 0.0002
415 MUSCLE TIGHTNESS 3 0.0002
416 HIP SURGERY 1 0.0002
417 SKIN LACERATION 2 0.0002
418 PRODUCT PRESCRIBING ISSUE 4 0.0002
419 HYDROCEPHALUS 1 0.0002
420 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
421 ASPIRATION 2 0.0002
422 MULTIPLE FRACTURES 3 0.0002
423 VENTRICULAR TACHYCARDIA 3 0.0002
424 TOOTH FRACTURE 2 0.0002
425 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
426 PROSTATIC DISORDER 1 0.0002
427 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
428 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
429 ANGIOPATHY 1 0.0002
430 ANGER 6 0.0002
431 PREMATURE LABOUR 1 0.0002
432 INSOMNIA 47 0.0002
433 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
434 MYOCARDITIS 2 0.0002
435 MUSCULOSKELETAL DISCOMFORT 3 0.0002
436 PARANOIA 3 0.0002
437 VASCULITIS 2 0.0002
438 HYPERKALAEMIA 6 0.0002
439 HYPOVOLAEMIA 1 0.0002
440 PSYCHOTIC DISORDER 5 0.0002
441 SINUS HEADACHE 1 0.0002
442 MYOCLONUS 2 0.0002
443 RESPIRATORY DISORDER 5 0.0002
444 IRRITABILITY 10 0.0002
445 RASH PRURITIC 9 0.0002
446 HEPATITIS C 2 0.0002
447 EMOTIONAL DISTRESS 20 0.0002
448 SEIZURE 19 0.0002
449 ACCIDENTAL OVERDOSE 6 0.0002
450 HAEMATOCHEZIA 9 0.0002
451 RECTAL HAEMORRHAGE 7 0.0002
452 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
453 PNEUMONIA ASPIRATION 4 0.0002
454 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
455 BLEPHAROSPASM 1 0.0002
456 PHOTOPSIA 1 0.0002
457 ENTERITIS 1 0.0002
458 ACUTE RESPIRATORY FAILURE 3 0.0002
459 INCOHERENT 1 0.0002
460 POOR QUALITY DRUG ADMINISTERED 1 0.0002
461 ANGINA UNSTABLE 1 0.0002
462 PRODUCT PREPARATION ISSUE 1 0.0002
463 OSTEONECROSIS 5 0.0002
464 SINUS DISORDER 3 0.0002
465 APPETITE DISORDER 1 0.0002
466 BRADYCARDIA 8 0.0002
467 PRURITUS 57 0.0001
468 METASTASES TO LYMPH NODES 1 0.0001
469 SINUS CONGESTION 2 0.0001
470 DRY MOUTH 12 0.0001
471 ABNORMAL LOSS OF WEIGHT 1 0.0001
472 PRODUCTIVE COUGH 7 0.0001
473 RASH ERYTHEMATOUS 7 0.0001
474 EYE MOVEMENT DISORDER 1 0.0001
475 ECCHYMOSIS 1 0.0001
476 CHRONIC KIDNEY DISEASE 11 0.0001
477 MENTAL STATUS CHANGES 4 0.0001
478 FORMICATION 1 0.0001
479 RIGHT VENTRICULAR FAILURE 1 0.0001
480 BLISTER 8 0.0001
481 SKIN REACTION 2 0.0001
482 DIVERTICULUM 1 0.0001
483 ANXIETY 40 0.0001
484 JOINT INJURY 3 0.0001
485 FEAR OF INJECTION 1 0.0001
486 METASTASIS 1 0.0001
487 HYPERSOMNIA 4 0.0001
488 PRURITUS GENERALISED 3 0.0001
489 PANIC REACTION 1 0.0001
490 BLOOD CREATININE INCREASED 9 0.0001
491 DRUG EFFECT INCOMPLETE 5 0.0001
492 C-REACTIVE PROTEIN INCREASED 5 0.0001
493 INTENTIONAL UNDERDOSE 1 0.0001
494 RESTLESSNESS 5 0.0001
495 ORAL DISORDER 1 0.0001
496 BLINDNESS TRANSIENT 1 0.0001
497 CEREBRAL DISORDER 1 0.0001
498 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
499 WHEEZING 8 0.0001
500 RENAL INJURY 4 0.0001
501 FEELING DRUNK 1 0.0001
502 DIZZINESS 67 0.0001
503 COLITIS ULCERATIVE 6 0.0001
504 SNEEZING 3 0.0001
505 PANCREATITIS ACUTE 3 0.0001
506 HALLUCINATION 10 0.0001
507 HAEMODYNAMIC INSTABILITY 1 0.0001
508 HEADACHE 82 0.0001
509 FEELING ABNORMAL 31 0.0001
510 BURNING SENSATION 9 0.0001
511 GASTROINTESTINAL INFLAMMATION 1 0.0001
512 MULTIPLE ALLERGIES 1 0.0001
513 AFFECTIVE DISORDER 1 0.0001
514 DRUG SCREEN POSITIVE 1 0.0001
515 ERYTHEMA 26 0.0001
516 RENAL CYST 1 0.0001
517 HALLUCINATION, AUDITORY 2 0.0001
518 LOW BIRTH WEIGHT BABY 1 0.0001
519 GINGIVAL PAIN 1 0.0001
520 ATRIAL FLUTTER 1 0.0001
521 MYASTHENIA GRAVIS 1 0.0001
522 MALAISE 54 0.0001
523 ABNORMAL FAECES 1 0.0001
524 DRUG LEVEL INCREASED 2 0.0001
525 MENSTRUAL DISORDER 1 0.0001
526 ACUTE CORONARY SYNDROME 1 0.0001
527 MUSCLE INJURY 1 0.0001
528 SECOND PRIMARY MALIGNANCY 1 0.0001
529 POLLAKIURIA 5 0.0001
530 HAEMODIALYSIS 1 0.0001
531 DRUG USE DISORDER 1 0.0001
532 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
533 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
534 SKIN PLAQUE 1 0.0001
535 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
536 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
537 ACUTE KIDNEY INJURY 18 0.0001
538 PRODUCT USE ISSUE 22 0.0001
539 RASH 51 0.0001
540 PSEUDOMONAS INFECTION 1 0.0001
541 ILLNESS 12 0.0001
542 HYSTERECTOMY 1 0.0001
543 PYELONEPHRITIS 1 0.0001
544 DELIRIUM 4 0.0001
545 RASH MACULAR 4 0.0001
546 METASTASES TO LIVER 2 0.0001
547 URTICARIA 19 0.0001
548 HYPERSENSITIVITY 21 0.0001
549 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
550 HEAD DISCOMFORT 2 0.0001
551 GASTROINTESTINAL INFECTION 1 0.0001
552 DISTURBANCE IN ATTENTION 6 0.0001
553 ANAL INCONTINENCE 1 0.0001
554 CRYING 4 0.0001
555 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
556 NAUSEA 86 0.0001
557 TREMOR 18 0.0001
558 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
559 PRODUCT DISTRIBUTION ISSUE 1 0.0001
560 DYSGEUSIA 8 0.0001
561 PERSONALITY CHANGE 1 0.0001
562 THINKING ABNORMAL 2 0.0001
563 HEPATIC ENCEPHALOPATHY 1 0.0001
564 NEPHROPATHY 1 0.0001
565 DIARRHOEA HAEMORRHAGIC 1 0.0001
566 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
567 LACERATION 1 0.0001
568 DYSARTHRIA 4 0.0001
569 DYSPNOEA EXERTIONAL 4 0.0001
570 LEUKAEMIA 1 0.0001
571 SLEEP APNOEA SYNDROME 2 0.0001
572 ANGINA PECTORIS 3 0.0001
573 PULMONARY FIBROSIS 2 0.0001
574 DRUG PRESCRIBING ERROR 2 0.0001
575 AFFECT LABILITY 1 0.0001
576 PRESCRIBED OVERDOSE 2 0.0001
577 HYPOGLYCAEMIA 5 0.0001
578 DYSSTASIA 3 0.0001
579 TACHYCARDIA 9 0.0001
580 HOSPICE CARE 1 0.0001
581 DISABILITY 2 0.0001
582 LIGAMENT SPRAIN 1 0.0001
583 DEPRESSION 23 0.0001
584 UPPER LIMB FRACTURE 2 0.0001
585 OVARIAN CYST 1 0.0001
586 BLOOD POTASSIUM DECREASED 3 0.0001
587 PREMATURE BABY 3 0.0001
588 LACRIMATION INCREASED 3 0.0001
589 PRODUCT PHYSICAL ISSUE 2 0.0001
590 FEEDING DISORDER 2 0.0001
591 EYELID PTOSIS 1 0.0001
592 NEUTROPHIL COUNT INCREASED 1 0.0001
593 THERAPY CESSATION 5 0.0001
594 HELICOBACTER INFECTION 1 0.0001
595 RIB FRACTURE 2 0.0001
596 CHEST PAIN 18 0.0001
597 EYE DISCHARGE 1 0.0001
598 SWELLING 9 0.0001
599 SWOLLEN TONGUE 3 0.0001
600 VOMITING 45 0.0001
601 CARDIO-RESPIRATORY ARREST 4 0.0001
602 PAIN IN EXTREMITY 28 0.0001
603 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
604 SCRATCH 1 0.0001
605 HALLUCINATION, VISUAL 2 0.0001
606 INCONTINENCE 1 0.0001
607 MIGRAINE 9 0.0001
608 BODY HEIGHT DECREASED 1 0.0001
609 CONTUSION 9 0.0001
610 MOVEMENT DISORDER 3 0.0001
611 HIP FRACTURE 3 0.0001
612 HEREDITARY ANGIOEDEMA 1 0.0001
613 HYPOACUSIS 4 0.0001
614 POOR QUALITY SLEEP 2 0.0001
615 DECREASED ACTIVITY 1 0.0001
616 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
617 MENSTRUATION DELAYED 1 0.0001
618 OEDEMA 5 0.0001
619 SEPTIC SHOCK 4 0.0001
620 DYSPEPSIA 9 0.0001
621 INTENTIONAL PRODUCT USE ISSUE 8 0.0001
622 PAIN 56 0.0001
623 GASTROINTESTINAL PAIN 1 0.0001
624 INFUSION RELATED REACTION 6 0.0001
625 ASTHENIA 34 0.0001
626 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
627 BLOOD PRESSURE DECREASED 6 0.0001
628 FOOT DEFORMITY 1 0.0001
629 DYSPNOEA 51 0.0001
630 LIP SWELLING 3 0.0001
631 STEVENS-JOHNSON SYNDROME 2 0.0001
632 TOOTH DISORDER 2 0.0001
633 SOMNOLENCE 18 0.0001
634 ORAL PAIN 2 0.0001
635 RASH PAPULAR 2 0.0001
636 THROAT IRRITATION 4 0.0001
637 ANAEMIA 17 0.0001
638 EYE INFECTION 1 0.0001
639 HEART RATE IRREGULAR 2 0.0001
640 REBOUND EFFECT 1 0.0001
641 HEPATIC ENZYME INCREASED 6 0.0001
642 IMPAIRED DRIVING ABILITY 1 0.0001
643 MYOCARDIAL ISCHAEMIA 1 0.0001
644 MICTURITION URGENCY 1 0.0001
645 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001
646 CAESAREAN SECTION 1 0.0001
647 HEART RATE DECREASED 3 0.0001
648 BONE PAIN 5 0.0001
649 SEXUAL DYSFUNCTION 1 0.0001
650 LYMPHADENOPATHY 3 0.0001
651 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
652 BLOOD IRON DECREASED 1 0.0001
653 BACTERAEMIA 1 0.0001
654 CHOLECYSTITIS 1 0.0001
655 HYPERLIPIDAEMIA 1 0.0001
656 DRUG INTOLERANCE 8 0.0001
657 BURSITIS 1 0.0001
658 PANIC ATTACK 3 0.0001
659 NO THERAPEUTIC RESPONSE 1 0.0001
660 AGITATION 6 0.0001
661 RESPIRATORY DEPRESSION 1 0.0001
662 MUSCLE SPASTICITY 1 0.0001
663 HEART RATE INCREASED 8 0.0001
664 PHARYNGITIS 1 0.0001
665 EXTRAPYRAMIDAL DISORDER 2 0.0001
666 AGEUSIA 2 0.0001
667 DRUG WITHDRAWAL SYNDROME 7 0.0001
668 CELLULITIS 4 0.0001
669 BRAIN OEDEMA 1 0.0001
670 ABDOMINAL PAIN LOWER 2 0.0001
671 HAEMATEMESIS 2 0.0001
672 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
673 CHEST DISCOMFORT 8 0.0001
674 MYDRIASIS 1 0.0001
675 ADVERSE DRUG REACTION 7 0.0001
676 ROTATOR CUFF SYNDROME 1 0.0001
677 DRUG RESISTANCE 2 0.0001
678 GENITAL HAEMORRHAGE 1 0.0001
679 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 14 0.0001
680 HYPERHIDROSIS 10 0.0001
681 HAEMATOMA 2 0.0001
682 RESPIRATORY TRACT INFECTION 2 0.0001
683 PLATELET COUNT INCREASED 1 0.0001
684 ABDOMINAL DISTENSION 8 0.0001
685 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
686 SARS-COV-2 TEST POSITIVE 1 0.0001
687 DISORIENTATION 3 0.0001
688 DEPRESSED MOOD 4 0.0001
689 HYPOTENSION 15 0.0001
690 CARDIAC FAILURE CONGESTIVE 6 0.0001
691 QUALITY OF LIFE DECREASED 1 0.0001
692 JAUNDICE 2 0.0001
693 PAIN OF SKIN 2 0.0001
694 OVERDOSE 16 0.0001
695 THROAT TIGHTNESS 2 0.0001
696 LIMB INJURY 2 0.0001
697 NEUTROPHIL COUNT DECREASED 3 0.0001
698 DRUG TOXICITY 1 0.0001
699 IMPAIRED GASTRIC EMPTYING 1 0.0001
700 MOOD ALTERED 2 0.0001
701 AKATHISIA 1 0.0001
702 CORONARY ARTERY OCCLUSION 1 0.0001
703 PERIPHERAL COLDNESS 1 0.0001
704 CARDIAC ARREST 6 0.0001
705 HUNGER 1 0.0001
706 APHONIA 1 0.0001
707 HOSPITALISATION 11 0.0001
708 RENAL IMPAIRMENT 6 0.0001
709 PERIPHERAL SWELLING 11 0.0001
710 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
711 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
712 INTENTIONAL DOSE OMISSION 2 0.0001
713 ACCIDENTAL UNDERDOSE 1 0.0001
714 HYPOKINESIA 1 0.0001
715 FLUID OVERLOAD 1 0.0001
716 APATHY 1 0.0001
717 CONFUSIONAL STATE 11 0.0001
718 ANGIOEDEMA 3 0.0001
719 COUGH 19 0.0001
720 BRONCHITIS 5 0.0001
721 URINARY INCONTINENCE 2 0.0001
722 SKIN HAEMORRHAGE 1 0.0001
723 WEIGHT INCREASED 15 0.0001
724 HAEMORRHAGE INTRACRANIAL 1 0.0001
725 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
726 HYPOAESTHESIA 10 0.0001
727 HEPATIC FAILURE 2 0.0001
728 HYPOAESTHESIA ORAL 1 0.0001
729 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
730 PLEURAL EFFUSION 4 0.0001
731 DRUG DISPENSING ERROR 1 0.0001
732 TINNITUS 3 0.0001
733 HIP ARTHROPLASTY 1 0.0001
734 INJECTION SITE RASH 2 0.0001
735 DRUG ADMINISTRATION ERROR 2 0.0001
736 PHARYNGEAL OEDEMA 1 0.0001
737 DEVICE RELATED INFECTION 1 0.0001
738 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
739 MUSCULOSKELETAL CHEST PAIN 1 0.0001
740 WEIGHT DECREASED 18 0.0001
741 ABDOMINAL PAIN 15 0.0001
742 DELUSION 1 0.0001
743 LUNG INFECTION 1 0.0001
744 EXPOSURE DURING PREGNANCY 4 0.0001
745 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3 0.0001
746 BASAL CELL CARCINOMA 1 0.0001
747 ARRHYTHMIA 3 0.0001
748 PULMONARY EMBOLISM 6 0.0001
749 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
750 PNEUMOTHORAX 1 0.0001
751 SCIATICA 1 0.0001
752 HYPOTHYROIDISM 2 0.0001
753 BLOOD GLUCOSE DECREASED 3 0.0001
754 SENSORY DISTURBANCE 1 0.0001
755 ASTHMA 7 0.0001
756 BLOOD POTASSIUM INCREASED 1 0.0001
757 BACK DISORDER 1 0.0001
758 LUNG DISORDER 3 0.0001
759 CHOLELITHIASIS 2 0.0001
760 METASTASES TO BONE 1 0.0001
761 MANIA 1 0.0001
762 INFLUENZA LIKE ILLNESS 5 0.0001
763 PHOTOSENSITIVITY REACTION 1 0.0001
764 DECREASED APPETITE 14 0.0001
765 RENAL FAILURE 8 0.0001
766 DRUG ABUSE 5 0.0001
767 LEUKOPENIA 3 0.0001
768 DEHYDRATION 8 0.0001
769 SYNCOPE 6 0.0001
770 SKIN DISORDER 2 0.0001
771 AGGRESSION 3 0.0001
772 URINARY RETENTION 2 0.0001
773 CHILLS 7 0.0001
774 CONSTIPATION 13 0.0001
775 FACE OEDEMA 1 0.0001
776 BLOOD PRESSURE INCREASED 9 0.0001
777 METRORRHAGIA 1 0.0001
778 SINUSITIS 6 0.0001
779 LOCAL SWELLING 1 0.0001
780 MUSCULOSKELETAL PAIN 3 0.0001
781 SPEECH DISORDER 3 0.0001
782 INCORRECT DOSE ADMINISTERED 13 0.0001
783 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
784 LYMPHOCYTE COUNT DECREASED 1 0.0001
785 DRUG DEPENDENCE 9 0.0001
786 CONDITION AGGRAVATED 17 0.0001
787 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
788 PNEUMONIA 18 0.0001
789 GASTROENTERITIS VIRAL 1 0.0001
790 OSTEOMYELITIS 1 0.0001
791 PELVIC PAIN 1 0.0001
792 RESTLESS LEGS SYNDROME 1 0.0001
793 RESPIRATORY FAILURE 4 0.0001
794 UNDERDOSE 4 0.0001
795 DEPENDENCE 3 0.0001
796 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
797 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
798 MUSCLE SPASMS 10 0.0001
799 DYSURIA 2 0.0001
800 MEDICATION ERROR 3 0.0001
801 HEPATIC STEATOSIS 1 0.0001
802 BACTERIAL INFECTION 1 0.0001
803 OXYGEN SATURATION DECREASED 3 0.0001
804 HYPONATRAEMIA 3 0.0001
805 HEPATIC CIRRHOSIS 1 0.0001
806 HOT FLUSH 4 0.0001
807 FLATULENCE 3 0.0001
808 PROTEINURIA 1 0.0001
809 MUSCULOSKELETAL DISORDER 1 0.0001
810 CONVULSION 3 0.0001
811 CHOLESTASIS 1 0.0001
812 POST PROCEDURAL COMPLICATION 1 0.0001
813 SEROTONIN SYNDROME 1 0.0001
814 LOWER LIMB FRACTURE 1 0.0001
815 ERUCTATION 1 0.0001
816 BACK PAIN 12 0.0001
817 PRODUCT QUALITY ISSUE 7 0.0001
818 DYSPHONIA 3 0.0001
819 SKIN FISSURES 1 0.0001
820 NASAL CONGESTION 3 0.0001
821 KIDNEY INFECTION 1 0.0001
822 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
823 ABNORMAL BEHAVIOUR 2 0.0001
824 BLOOD PRESSURE ABNORMAL 1 0.0001
825 CYTOKINE RELEASE SYNDROME 1 0.0000
826 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
827 PRODUCT ADMINISTRATION ERROR 1 0.0000
828 ILL-DEFINED DISORDER 3 0.0000
829 EXTRA DOSE ADMINISTERED 2 0.0000
830 VERTIGO 3 0.0000
831 DYSKINESIA 2 0.0000
832 DISCOMFORT 3 0.0000
833 PYREXIA 17 0.0000
834 FEELING HOT 3 0.0000
835 LUNG NEOPLASM MALIGNANT 2 0.0000
836 DIARRHOEA 31 0.0000
837 COMPLETED SUICIDE 4 0.0000
838 ROAD TRAFFIC ACCIDENT 2 0.0000
839 MOUTH ULCERATION 1 0.0000
840 SKIN EXFOLIATION 4 0.0000
841 HYPERTENSION 10 0.0000
842 GAIT DISTURBANCE 9 0.0000
843 RETCHING 1 0.0000
844 LOSS OF CONSCIOUSNESS 6 0.0000
845 IMPAIRED WORK ABILITY 1 0.0000
846 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
847 FAECES DISCOLOURED 1 0.0000
848 DEVICE LEAKAGE 2 0.0000
849 SWELLING FACE 3 0.0000
850 MENTAL DISORDER 2 0.0000
851 MYOCARDIAL INFARCTION 8 0.0000
852 MELAENA 1 0.0000
853 RASH MACULO-PAPULAR 1 0.0000
854 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
855 SEPSIS 5 0.0000
856 PULMONARY OEDEMA 2 0.0000
857 PARAESTHESIA 7 0.0000
858 THERAPY NON-RESPONDER 2 0.0000
859 PRODUCT DOSE OMISSION ISSUE 13 0.0000
860 NEUTROPENIA 6 0.0000
861 DRUG INTERACTION 7 0.0000
862 ADVERSE EVENT 4 0.0000
863 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
864 CARDIAC DISORDER 4 0.0000
865 INJURY 3 0.0000
866 FALL 14 0.0000
867 SKIN BURNING SENSATION 3 0.0000
868 MULTIPLE SCLEROSIS 2 0.0000
869 DIABETIC KETOACIDOSIS 1 0.0000
870 TOXICITY TO VARIOUS AGENTS 7 0.0000
871 CEREBROVASCULAR ACCIDENT 7 0.0000
872 MENTAL IMPAIRMENT 1 0.0000
873 MYALGIA 7 0.0000
874 FIBROMYALGIA 1 0.0000
875 NEURALGIA 1 0.0000
876 ATRIAL FIBRILLATION 4 0.0000
877 OEDEMA PERIPHERAL 5 0.0000
878 CEREBRAL INFARCTION 1 0.0000
879 INJECTION SITE URTICARIA 1 0.0000
880 ABASIA 1 0.0000
881 VISUAL IMPAIRMENT 5 0.0000
882 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
883 HYPOPHAGIA 1 0.0000
884 HAEMOGLOBIN DECREASED 4 0.0000
885 NO ADVERSE EVENT 7 0.0000
886 RASH GENERALISED 1 0.0000
887 FATIGUE 30 0.0000
888 DIPLOPIA 1 0.0000
889 ECZEMA 2 0.0000
890 MUCOSAL INFLAMMATION 1 0.0000
891 SEDATION 1 0.0000
892 ARTHRITIS 3 0.0000
893 JOINT STIFFNESS 1 0.0000
894 EAR INFECTION 1 0.0000
895 FEAR 1 0.0000
896 DRUG EFFECT DECREASED 2 0.0000
897 PALLOR 1 0.0000
898 OFF LABEL USE 32 0.0000
899 SKIN LESION 1 0.0000
900 VISION BLURRED 5 0.0000
901 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
902 RESPIRATORY DISTRESS 1 0.0000
903 DIVERTICULITIS 1 0.0000
904 NECK PAIN 2 0.0000
905 ABDOMINAL DISCOMFORT 6 0.0000
906 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
907 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
908 HERPES ZOSTER 2 0.0000
909 LETHARGY 2 0.0000
910 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
911 BALANCE DISORDER 3 0.0000
912 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
913 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
914 ASCITES 1 0.0000
915 ABDOMINAL PAIN UPPER 7 0.0000
916 ACUTE MYOCARDIAL INFARCTION 1 0.0000
917 DISEASE PROGRESSION 4 0.0000
918 ARTHRALGIA 14 0.0000
919 JOINT SWELLING 4 0.0000
920 APHASIA 1 0.0000
921 CORONARY ARTERY DISEASE 1 0.0000
922 SUICIDAL IDEATION 3 0.0000
923 EPILEPSY 1 0.0000
924 NASOPHARYNGITIS 6 0.0000
925 NERVOUS SYSTEM DISORDER 1 0.0000
926 HEAD INJURY 1 0.0000
927 NEUROPATHY PERIPHERAL 3 0.0000
928 METABOLIC ACIDOSIS 1 0.0000
929 AMNESIA 2 0.0000
930 PRODUCT DOSE OMISSION 2 0.0000
931 IMPAIRED HEALING 1 0.0000
932 FUNGAL INFECTION 1 0.0000
933 EYE PRURITUS 1 0.0000
934 URINARY TRACT INFECTION 5 0.0000
935 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
936 GASTRIC DISORDER 1 0.0000
937 MEMORY IMPAIRMENT 4 0.0000
938 HAEMORRHAGE 3 0.0000
939 PLATELET COUNT DECREASED 3 0.0000
940 THERAPY INTERRUPTED 2 0.0000
941 MOBILITY DECREASED 2 0.0000
942 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
943 INJECTION SITE MASS 1 0.0000
944 INFLUENZA 3 0.0000
945 EYE SWELLING 1 0.0000
946 EPISTAXIS 2 0.0000
947 UNEVALUABLE EVENT 2 0.0000
948 MUSCULAR WEAKNESS 3 0.0000
949 DIABETES MELLITUS 2 0.0000
950 ABORTION SPONTANEOUS 1 0.0000
951 DEVICE BREAKAGE 1 0.0000
952 BLINDNESS 1 0.0000
953 DRUG DOSE OMISSION 4 0.0000
954 TREATMENT FAILURE 2 0.0000
955 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
956 OSTEOARTHRITIS 1 0.0000
957 MUSCULOSKELETAL STIFFNESS 2 0.0000
958 LIVER DISORDER 1 0.0000
959 GASTROINTESTINAL DISORDER 2 0.0000
960 NEPHROLITHIASIS 1 0.0000
961 OROPHARYNGEAL PAIN 2 0.0000
962 RENAL DISORDER 1 0.0000
963 BLOOD CHOLESTEROL INCREASED 1 0.0000
964 COGNITIVE DISORDER 1 0.0000
965 OCULAR HYPERAEMIA 1 0.0000
966 DISEASE RECURRENCE 1 0.0000
967 COMA 1 0.0000
968 INFECTION 3 0.0000
969 DRY EYE 1 0.0000
970 FLUID RETENTION 1 0.0000
971 INFLAMMATION 1 0.0000
972 DEATH 16 0.0000
973 ANAPHYLACTIC REACTION 1 0.0000
974 EYE PAIN 1 0.0000
975 EYE IRRITATION 1 0.0000
976 COVID-19 3 0.0000
977 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
978 BLOOD GLUCOSE INCREASED 3 0.0000
979 RHINORRHOEA 1 0.0000
980 DEEP VEIN THROMBOSIS 1 0.0000
981 FEBRILE NEUTROPENIA 1 0.0000
982 DRY SKIN 2 0.0000
983 INJECTION SITE REACTION 1 0.0000
984 DEVICE MALFUNCTION 1 0.0000
985 INJECTION SITE SWELLING 1 0.0000
986 CARDIAC FAILURE 1 0.0000
987 DEVICE ISSUE 1 0.0000
988 DYSPHAGIA 1 0.0000
989 ALOPECIA 2 0.0000
990 INJECTION SITE ERYTHEMA 1 0.0000
991 PSORIASIS 1 0.0000
992 INJECTION SITE PAIN 2 0.0000